Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Movement in the Tylenol murders: Law enforcement seeks to persuade prosecutors to act on ‘chargeable’ case

CHICAGO — As the 40th anniversary of the 1982 Tylenol murders approaches, investigators are working with prosecutors on a now-or-maybe-never effort to hold a longtime suspect responsible for the poisonings that killed seven people in the Chicago area, the Tribune has learned.

Chicago Tribune

Action on faulty vaginal mesh took too long, now women struggle to access mesh surgery that works

Last week, Johnson Johnson reached a A$300 million settlement for two class actions brought by Australian women affected by complications from vaginal mesh products.

The Conversation

J&J tried to block lawsuits from 40,000 cancer patients. A court wants answers

Critics say a legal maneuver by one of the world's wealthiest corporations could set a precedent, allowing non-bankrupt companies and rich individuals to avoid liability for wrongdoing.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

This Is What Whales Are Betting On Johnson & Johnson

A whale with a lot of money to spend has taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 10 strange trades.

Benzinga

Pelvic mesh class action $300m payout: but who will get the money?

Further details about the Johnson & Johnson class action are expected to emerge on Friday

Newcastle Herald

$300 million settlement for pelvic mesh class actions

In an announcement Monday, Shine Lawyers revealed the mammoth settlement which will go towards women injured by being implanted with Johnson & Johnson's pelvic mesh and vaginal tape devices.

Newcastle Herald

Check Out What Whales Are Doing With JNJ

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 12 strange trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Johnson Johnson Will Pay $300M To Women Who’ve Suffered From Pelvic Mesh Implant Complications

The settlement will help cover women's ongoing treatment for injuries caused by the mesh implants.

Pedestrian.tv

Pelvic mesh class actions settle for $300m

Two class actions against Johnson & Johnson over defective pelvic mesh products have settled for $300 million, finalising almost 10 years of legal fighting.

AAP

Johnson & Johnson reaches $300m settlement over pelvic mesh implants

Settlement of two Australian class actions is largest in country’s history and subject to federal court approval

The Guardian - AU

Johnson & Johnson Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

This Is What Whales Are Betting On Johnson & Johnson

Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Johnson & Johnson Whale Trades For August 23

Benzinga

Pharma funds Illinois pols, ‘Sister Jean’ turns 103, Honest Chicagoans talk Air and Water Show and more in your Chicago news roundup

Today’s update is a 5-minute read that will brief you on the day’s biggest stories.

Chicago Sun-Times

Get all your
news in one place.

100's of premium titles.
One news app.

Chicago Sun-Times

Illinois Senate President Don Harmon, other pols keep taking money from pharma companies implicated in opioid crisis

The Oak Park Democrat continues to accept campaign money from Johnson & Johnson, 1 of 4 companies paying $26 billion to settle suits accusing them of fueling the crisis. He’s not the only Illinois official doing so.

Benzinga

If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Daily Record

Johnson & Johnson baby powder to be removed from all UK stores in 2023

The company cites commercial reasons and has blamed 'misinformation' over the safety of the product for its declining sales in the past.

Tribune News Service

More than a half billion doses of COVID vaccine made in Baltimore dumped, congressional panel finds

BALTIMORE — The tally of wasted COVID-19 vaccine continues to climb at the troubled Emergent BioSolutions plant in East Baltimore and now exceeds a half billion doses, according to findings a congressional panel released Thursday on the manufacturer once central to the U.S. coronavirus pandemic response.

Get all your
news in one place.

100's of premium titles.
One news app.

Los Angeles Times

Walgreens fueled San Francisco's opioid crisis with thousands of 'suspicious orders,' judge rules

Walgreens helped fuel the opioid epidemic in San Francisco by shipping hundreds of thousands of "suspicious orders" of prescription drugs to its pharmacies, a federal judge ruled Wednesday.

Benzinga

Johnson & Johnson Whale Trades Spotted

WEKU

New book chronicles how America's opioid industry operated like a drug cartel

Two Washington Post journalists say pharmaceutical companies collaborated with each other — and with lawyers and lobbyists — to create laws to protect the industry. Their new book is American Cartel.

Benzinga

Johnson & Johnson Whale Trades For July 25

Benzinga

Things Looking Up at Johnson & Johnson?

Johnson & Johnson (NYSE: JNJ) released their financial report for the second quarter of 2022, this week, demonstrating strong growth and promising guidance for the rest of the year. Analysts seem to agree, as the consensus rating for JNJ is MODERATE BUY.

Benzinga

US Stock Futures Higher Ahead of J&J, Netflix Earnings

Pre-open movers

The Independent UK

Covid vaccine protection ‘short lived,’ booster doses essential, study confirms

‘Continual updating of our vaccinations and booster shots is critical,’ scientists say

1 … 13 14 15 16

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.